|
"lien huang chun"的相關文件
顯示項目 16-25 / 64 (共7頁)
<< < 1 2 3 4 5 6 7 > >>
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2016 |
An incidental pulmonary part-solid ground-glass nodule in a patient under anticoagulant therapy
|
Chen, Jo-Yu; Lien, Huang-Chun; Chen, Jin-Shing; Chang, Yeun-Chung; 連晃駿; 張允中; 陳若瑀; 陳晉興 |
| 國立臺灣大學 |
2016 |
Mutational analysis of MED12 exon 2 in a spectrum of fibroepithelial tumours of the breast: implications for pathogenesis and histogenesis
|
Lien, Huang-Chun; Huang, Chiun-Sheng; Yang, Ya-Wen; Jeng, Yung-Ming; 鄭永銘; 連晃駿; 楊雅雯; 黃俊升 |
| 國立臺灣大學 |
2016 |
MED12 exon 2 mutation as a highly sensitive and specific marker in distinguishing phyllodes tumours from other spindle neoplasms of the breast
|
Lien, Huang-Chun; Huang, Chiun-Sheng; Yang, Ya-Wen; Jeng, Yung-Ming; 鄭永銘; 連晃駿; 楊雅雯; 黃俊升 |
| 國立臺灣大學 |
2016 |
SPOCK1 Is a Novel Transforming Growth Factor-beta-Induced Myoepithelial Marker That Enhances Invasion and Correlates with Poor Prognosis in Breast Cancer
|
Fan, Li-Ching; Jeng, Yung-Ming; Lu, Yueh-Tong; Lien, Huang-Chun; 鄭永銘; 連晃駿 |
| 國立臺灣大學 |
2016 |
Locoregional Recurrence Risk for Postmastectomy Breast Cancer Patients With T1-2 and One to Three Positive Lymph Nodes Receiving Modern Systemic Treatment Without Radiotherapy
|
Lai, Shih-Fan; Chen, Yu-Hsuan; Kuo, Wen-Hung; Lien, Huang-Chun; Wang, Ming-Yang; Lu, Yen-Shen; Lo, Chiao; Kuo, Sung-Hsin; Cheng, Ann-Lii; Huang, Chiun-Sheng; 郭文宏; 盧彥伸; 連晃駿; 郭頌鑫; 鄭安理; 陳育瑄; 黃俊升; 王明暘 |
| 國立臺灣大學 |
2016 |
PRRX2 as a novel TGF--induced factor enhances invasion and migration in mammary epithelial cell and correlates with poor prognosis in breast cancer
|
Juang, Yu-Lin; Jeng, Yung-Ming; Chen, Chi-Long; Lien, Huang-Chun; 鄭永銘; 連晃駿 |
| 國立臺灣大學 |
2015 |
Frequent alterations of HER2 through mutation, amplification, or overexpression in pleomorphic lobular carcinoma of the breast
|
Lien, Huang-Chun; Chen, Yu-Ling; Juang, Yu-Lin; Jeng, Yung-Ming; 鄭永銘; 連晃駿 |
| 國立臺灣大學 |
2015 |
Randomized study of tailored neoadjuvant chemotherapy according to the expression of tau, topo II alpha, and ERCC1 versus standard chemotherapy in HER2-negative breast cancer
|
Lu, Yen-Shen; Yeh, Dah-Cherng; Tseng, Ling-Ming; Chen, Shou-Tung; Lien, Huang-Chun; Chang, Hong-Tai; Chang, Yuan-Ching; Huang, Shu-Min; Lin, Ching-Hung; Cheng, Ann-Lii; Huang, Chiun-Sheng; 盧彥伸; 林璟宏; 連晃駿; 鄭安理; 黃俊升 |
| 國立臺灣大學 |
2015 |
Prognostic significance of clinicopathologic features in patients with breast ductal carcinoma in situ who received breast-conserving therapy.
|
Kuo, Sung Hsin; Chen, Yu-Hsuan; Kuo, Wen-Hung; Lien, Huang-Chun; Wang, Ming-Yang; Wang, Chao-Ping; Huang, Chiun-Sheng; 郭文宏; 連晃駿; 郭頌鑫; 陳育瑄; 黃俊升; 王明暘 |
| 國立臺灣大學 |
2015 |
Phosphorylation of EZH2 at T416 by CDK2 contributes to the malignancy of triple negative breast cancers
|
Yang, Cheng-Chieh; LaBaff, Adam; Wei, Yongkun; Nie, Lei; Xia, Weiya; Huo, Longfei; Yamaguchi, Hirohito; Hsu, Yi-Hsin; Hsu, Jennifer L.; Liu, Dongping; Lang, Jingyu; Du, Yi; Lien, Huang-Chun; Li, Long-Yuan; Deng, Rong; Chan, Li-Chuan; Yao, Jun; Kleer, Celina G.; Hortobagyi, Gabriel N.; Hung, Mien-Chie; 連晃駿 |
顯示項目 16-25 / 64 (共7頁)
<< < 1 2 3 4 5 6 7 > >>
每頁顯示[10|25|50]項目
|
